“Best Practice Guidelines for Probiotics”

New Scientific Guidelines for Probiotics Emerge

Transparency, ingredients, and clear labeling are important to consumers of nutritional supplements and probiotics. These are also substantial to reputable manufacturers in these markets looking to educate consumers on product benefits and to distance their brands from products on the market with less science supporting their claims and benefits.

In January 2017, the Council for Responsible Nutrition and the International Probiotics Association collaboratively published “Best Practice Guidelines for Probiotics” as a proactive set of voluntary, scientifically-based guidelines to encourage responsible production and marketing of dietary supplements and functional foods that contain probiotics. Continue reading

Trends in the U.S. jan/san market

The Game-changing Jan/San Market Trends

Kline is now working on our largest I&I market study, Janitorial and Housekeeping Cleaning Products: U.S. Market Analysis and Opportunities, and we have uncovered several trends that will significantly change the market in the near future.

Rising labor costs with minimum wage increases are driving industrial and institutional (I&I) end users to cut back on costs, which includes less spending on cleaning chemicals and/or reduced frequency of performing certain cleaning tasks. There is also some growth in private-label cleaning chemicals as end users seek low prices and value from their jan/san products. There are cycles of outsourcing and doing the work in-house among end users, such as office buildings and industrial parks. Continue reading

Beauty Retailing

2014 Beauty Acquisition Spree Continues, Plus Up-and-coming Players to Keep an Eye On

After a lull following the global recession of 2009, merger and acquisition activity heated back up in 2013 and strongly continues into 2014. Among the most notable transactions so far this year are Henkel’s acquisition of three U.S. professional hair care brands, Sexy Hair, Alterna, and Kenra; Bayer’s purchase of Merck’s OTC and consumer care business, including Coppertone and Dr. Scholl’s; and L’Oréal’s purchase of NYX Cosmetics. The beauty industry has clearly emerged from the recession with a number of buyers that have significant cash on the books who are searching for attractive (and often smaller, niche) beauty brands and are willing to pay more than in previous years. As such, brands that were previously off the market are reconsidering availability.Continue reading

P&G's Category-leading Brands

It’s Not Lonely at the Top: P&G’s Category-leading Brands Hit the Hardest in 2012

The latest market data just released by Kline on the U.S. beauty industry illustrates that although the market grew by 3.4% in 2012, there were varying levels of success where some of the key players fared better than others.

Procter & Gamble (P&G) remains the clear leader in the U.S. personal care market, which Kline defines to include fragrances, hair care products, makeup, oral care products, skin care products, and other toiletries, such as deodorants and soaps. Via both acquisition and organic growth, this leadership has solidified over the last decade. However, 2012 has proven to be one of the most challenging years to date, as P&G’s category-leading brands have lost footing in several categories including shampoos, toothpastes, and color cosmetics.Continue reading

Rx-to-OTC Switches Energize Solid OTC Drug Market Growth

Rx-to-OTC Switches Energize Solid OTC Drug Market Growth

Rx-to-OTC switch brands continue to be major game changers within the OTC market, whether promoting strong gains or causing steep declines. Aided by the launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) and strong growth of private labels, allergy relief products grew 16.3% in 2011 to become the fastest growing category on the U.S. OTC drug market, according to the Nonprescription Drugs USA 2011 report by international consulting and research firm Kline & Company. The U.S. OTC drug market posted a gain of 2.4% reaching $21.4 billion in 2011 at the manufacturers’ level.

Continue reading

U.S. OTC Market Posts Solid Growth in 2011 Driven by Rx-to-OTC Switches and Marketing

U.S. OTC Market Posts Solid Growth in 2011 Driven by Rx-to-OTC Switches and Marketing

From 2010 to 2011, the U.S. OTC drug market posted a gain of 2.4% from $20.9 billion in 2010 to $21.4 billion in 2011 at the manufacturers’ level. The fastest growing categories include allergy relief products, which grew 16.3% in 2011 aided by the market launch of Rx-to-OTC switch brand Allegra (Sanofi-Aventis) and the strong growth of private-label allergy relief products. Past Rx-to-OTC switch brands continue to perform well with Rogaine (Johnson & Johnson) and Plan B (Teva Pharmaceutical), both posting strong gains in the hair regrowth products and contraceptives markets, respectively.

Continue reading